ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients

NCT00396461 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: MCT/LCT (1:1)
DRUG: MCT/LCT/omega-3 (5:4:1)

Sponsor

B. Braun Medical SA